Advertisement
Advertisement

DRIO

DRIO logo

DarioHealth Corp. Common Stock

7.81
USD
Sponsored
-0.32
-3.88%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

7.84

+0.04
+0.45%

DRIO Earnings Reports

Positive Surprise Ratio

DRIO beat 19 of 37 last estimates.

51%

Next Report

In 2 Days
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$5.59M
/
-$1.50
Implied change from Q4 25 (Revenue/ EPS)
+6.94%
/
-56.27%
Implied change from Q1 25 (Revenue/ EPS)
-17.15%
/
-46.43%

DarioHealth Corp. Common Stock earnings per share and revenue

On Mar 19, 2026, DRIO reported earnings of -3.43 USD per share (EPS) for Q4 25, missing the estimate of -3.30 USD, resulting in a -3.71% surprise. Revenue reached 5.23 million, compared to an expected 5.15 million, with a 1.61% difference. The market reacted with a -4.29% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -1.50 USD, with revenue projected to reach 5.59 million USD, implying an decrease of -56.27% EPS, and increase of 6.94% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Artivion, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.05
Actual
$0.08
Surprise
+59.68%
logo
Tandem Diabetes Care, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.45
Actual
-$0.30
Surprise
+34.01%
logo
Pacific Biosciences of California, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.73%
logo
Delcath Systems Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.03
Surprise
+66.06%
logo
EDAP TMS SA
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.24
Surprise
-25.59%
logo
Treace Medical Concepts, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+10.88%
logo
Sensus Healthcare, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.16
Surprise
-25.49%
logo
LENSAR, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
$0.18
Actual
$0.00
Surprise
-100.00%
logo
Mettler-Toledo International
Report Date
May 07, 2026 For Q1 26
Estimate
$8.78
Actual
$8.91
Surprise
+1.37%
logo
GLOBUS MEDICAL INC
Report Date
May 07, 2026 For Q1 26
Estimate
$0.93
Actual
$1.12
Surprise
+19.39%
FAQ
For Q4 2025, DarioHealth Corp. Common Stock reported EPS of -$3.43, missing estimates by -3.71%, and revenue of $5.23M, 1.61% above expectations.
The stock price moved down -4.29%, changed from $9.56 before the earnings release to $9.15 the day after.
The next earning report is scheduled for May 12, 2026.
Based on 4 analysts, DarioHealth Corp. Common Stock is expected to report EPS of -$1.50 and revenue of $5.59M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement